Several forms of pneumonia can be prevented through vaccination, including pneumonia caused by pneumococcal bacteria, influenza, RSV, COVID-19, measles, and chickenpox. Pneumococcal vaccines offer the most direct protection, but flu shots, RSV vaccines, and childhood immunizations like MMR all reduce pneumonia risk by preventing the infections that cause it.
Pneumococcal Pneumonia
Pneumococcal bacteria are the single most common cause of bacterial pneumonia, and they’re also the form most directly targeted by vaccines. These bacteria normally live in the nose and throat and can cause infections ranging from mild ear infections to life-threatening pneumonia. Three main vaccine types exist: PCV15 (covering 15 bacterial strains), PCV20 (covering 20 strains), and PPSV23 (covering 23 strains). A newer option, PCV21, has also entered the lineup.
The protection these vaccines provide is substantial. PPSV23 protects 60 to 70% of healthy adults against invasive pneumococcal disease from the strains it covers. An earlier conjugate vaccine, PCV13, prevented pneumococcal pneumonia in roughly 45% of adults 65 and older in clinical studies, and also blocked antibiotic-resistant infections caused by the strains in the vaccine.
The CDC now recommends pneumococcal vaccination for all children under 5 (a four-dose series starting at 2 months) and for all adults 50 and older who haven’t previously received a pneumococcal conjugate vaccine. If you get PCV20 or PCV21, that single vaccine completes the series. If you get PCV15 instead, a dose of PPSV23 is recommended about a year later. Adults under 50 with certain risk factors, such as weakened immune systems, cochlear implants, or cerebrospinal fluid leaks, are also recommended to get vaccinated.
Influenza-Related Pneumonia
The flu doesn’t just cause fever and body aches. It can damage the lungs directly or weaken them enough for bacteria to move in, causing secondary bacterial pneumonia. This combination is a major driver of pneumonia hospitalizations every winter, especially among older adults.
Annual flu vaccination reduces pneumonia and influenza-related hospitalizations by 25 to 53%, based on pooled analyses across multiple studies. That wide range reflects differences in how well each year’s vaccine matches circulating flu strains, but even in a mismatch year, vaccination lowers the odds of the severe lung complications that land people in the hospital.
RSV Pneumonia
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in both young children and older adults. Vaccines approved for adults 60 and older have shown strong results. In a large clinical trial published in the New England Journal of Medicine, an mRNA-based RSV vaccine was 83.7% effective at preventing RSV-associated lower respiratory tract disease. Protection was even higher in adults with existing health conditions (88.4%) and in those aged 70 to 79 (95.4%).
RSV vaccines for maternal immunization and infant protection have also become available, targeting the age group most vulnerable to severe RSV lung infections.
COVID-19 Pneumonia
COVID-19 can cause viral pneumonia ranging from mild lung inflammation to severe acute respiratory distress. Vaccination doesn’t eliminate the risk of infection entirely, but it significantly reduces how much damage the virus does to the lungs. In a study of over 300 patients during the Delta and Omicron waves, vaccinated individuals had notably milder pneumonia visible on CT scans compared to unvaccinated patients. Those who received booster doses showed the least lung involvement, even though they tended to be older and have more underlying health conditions.
Measles and Chickenpox Pneumonia
Two childhood infections that most people associate with rashes, measles and chickenpox, are actually significant causes of pneumonia. Pneumonia is the most common fatal complication of measles, responsible for 56 to 86% of measles-related deaths. Measles vaccine (given as part of MMR) is 95% effective after one dose and 96% effective after two doses at preventing measles infection entirely, which eliminates the pneumonia risk along with it.
Chickenpox can also cause viral pneumonia, particularly in adults and immunocompromised individuals. The varicella vaccine is 95% effective at preventing chickenpox over a 10-year follow-up after two doses. By stopping the underlying infection, these vaccines remove the pathway to pneumonia altogether.
Hib Pneumonia in Children
Haemophilus influenzae type b (Hib) was once a major cause of pneumonia, meningitis, and other serious infections in young children. The Hib vaccine, now part of the routine childhood immunization schedule in most countries, has dramatically changed that picture. In Botswana, introducing the Hib vaccine followed by a pneumococcal conjugate vaccine was associated with a 48% drop in childhood pneumonia hospitalizations and a 50% reduction in pneumonia deaths. Across low- and middle-income countries more broadly, Hib vaccines prevent roughly 18% of X-ray-confirmed pneumonia cases in children.
How Multiple Vaccines Work Together
No single vaccine prevents all pneumonia, because pneumonia isn’t one disease. It’s a condition caused by dozens of different bacteria, viruses, and occasionally fungi. Each vaccine targets a specific pathogen. Pneumococcal vaccines handle the most common bacterial cause. Flu and COVID vaccines prevent viral pneumonia and reduce the risk of bacterial pneumonia that follows viral infections. RSV vaccines protect against a virus that’s especially dangerous at the extremes of age. Childhood vaccines like MMR, varicella, and Hib cover infections that would otherwise cause pneumonia in kids.
The practical takeaway is that staying current on recommended vaccines at every stage of life, from the infant series through adult boosters, layers multiple forms of pneumonia protection. For adults 50 and older, the combination of pneumococcal, flu, RSV, and COVID vaccines covers the most common infectious causes of severe pneumonia in that age group.